AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2024
Aug 7, 2024
30016_dirs_2024-08-07_ae61900a-97e4-4bc6-abe4-06e4aaa62275.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2024-08-05
Reporting Person: MCKEON BRIAN P (EVP, CFO and Treasurer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-05 | Common Stock | M | 192 | — | Acquired | 31048.5926 | Direct |
| 2024-08-05 | Common Stock | F | 117 | $455.08 | Disposed | 30931.5926 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-08-05 | Restricted Stock Unit | $ | M | 192 | Disposed | Common Stock (192) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 18050 | Indirect |
Footnotes
F1: (1) Includes a total of 22 shares purchased under the Issuer's Employee Stock Purchase Plan on March 29, 2024 and June 28, 2024.
F2: Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning August 5, 2020.
F3: Not applicable
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13